Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.
Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, Bansi L, Pillay D, Dunn D; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees. Barber TJ, et al. J Antimicrob Chemother. 2012 Apr;67(4):995-1000. doi: 10.1093/jac/dkr569. Epub 2012 Jan 17. J Antimicrob Chemother. 2012. PMID: 22258921
Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study.
Dolling DI, Dunn DT, Sutherland KA, Pillay D, Mbisa JL, Parry CM, Post FA, Sabin CA, Cane PA; UK HIV Drug Resistance Database (UKHDRD); UK Collaborative HIV Cohort Study (UK CHIC). Dolling DI, et al. J Antimicrob Chemother. 2013 Oct;68(10):2339-43. doi: 10.1093/jac/dkt199. Epub 2013 May 27. J Antimicrob Chemother. 2013. PMID: 23711895 Free PMC article.
Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions.
Hué S, Brown AE, Ragonnet-Cronin M, Lycett SJ, Dunn DT, Fearnhill E, Dolling DI, Pozniak A, Pillay D, Delpech VC, Leigh Brown AJ; UK Collaboration on HIV Drug Resistance and the Collaborative HIV, Anti-HIV Drug Resistance Network (CHAIN). Hué S, et al. Among authors: dolling di. AIDS. 2014 Aug 24;28(13):1967-75. doi: 10.1097/QAD.0000000000000383. AIDS. 2014. PMID: 24991999
Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study.
UK Collaborative Group on HIV Drug Resistance; Dolling D, Sabin C, Delpech V, Smit E, Pozniak A, Asboe D, Brown AL, Churchill D, Williams I, Geretti AM, Phillips A, Mackie N, Murphy G, Castro H, Pillay D, Cane P, Dunn D, Dolling D. UK Collaborative Group on HIV Drug Resistance, et al. Among authors: dolling d. BMJ. 2012 Aug 21;345:e5253. doi: 10.1136/bmj.e5253. BMJ. 2012. PMID: 22915687 Free PMC article.
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G, Mackie N, Bowman C, Lacey CJ, Apea V, Brady M, Fox J, Taylor S, Antonucci S, Khoo SH, Rooney J, Nardone A, Fisher M, McOwan A, Phillips AN, Johnson AM, Gazzard B, Gill ON. McCormack S, et al. Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9. Lancet. 2016. PMID: 26364263 Free PMC article. Clinical Trial.
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men.
Dolling D, Phillips AN, Delpech V, Pillay D, Cane PA, Crook AM, Shepherd J, Fearnhill E, Hill T, Dunn D; UK HIV Drug Resistance Database; UK Collaborative HIV Cohort (UK CHIC) Study. Dolling D, et al. HIV Med. 2012 May;13(5):309-14. doi: 10.1111/j.1468-1293.2011.00968.x. Epub 2011 Dec 12. HIV Med. 2012. PMID: 22151684 Free article.
69 results